Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer

Clinical Cancer Research

Volumn 14, Issue 17, 2008, Pages 5635-5639

  Cussenot, Olivier ^a,b   Azzouzi, Abdel Rahmène ^a,c   Bantsimba Malanda, Gladys ^a   Gaffory, Cecile ^a   Mangin, Philippe ^a,d   Cormier, Luc ^a,d   Fournier, Georges ^a,e   Valeri, Antoine ^a,e   Jouffe, Lionel ^f   Roupret, Morgan ^a,b   Fromont, Gaelle ^a,g   Sibony, Mathilde ^b   Comperat, Eva ^b   Cancel Tassin, Géraldine ^a  

^a HÔPITAL TENON   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d CHU NANCY BRABOIS   (France)

^e SERVICE DE RHUMATOLOGIE   (France)

^f Bayesia   (France)

^g POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER STAGING; CAUCASIAN; CHROMOSOME 8Q; CONTROLLED STUDY; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; SINGLE NUCLEOTIDE POLYMORPHISM; ADENOCARCINOMA; BAYES THEOREM; CHROMOSOME 8; DISEASE COURSE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BAYES THEOREM; CHROMOSOMES, HUMAN, PAIR 8; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS;

EID: 53049108930     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-4999     Document Type: Article

References (18)

1. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate 1990;17:337-47.
2. Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate- specific antigen level < or = 4.0 ng per milliliter. N Engl J Med 2004;350:2239-46.
3. Amundadottir LT, Sulem P, Gudmundsson J, et al. A common variant associated with prostate cancer in European and African populations. Nat Genet 2006;38:652-8.
4. Freedman ML, Haiman CA, Patterson N, et al. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci U S A 2006;103:14068-73.
5. Suuriniemi M, Agalliul, Schaid DJ, et al. Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24. Cancer Epidemiol Biomarkers Prev 2007;16:809-14.
6. Wang L, McDonnell SK, Slusser JP, et al. Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. Cancer Res 2007;67:2944-50.
7. Schumacher FR, Feigelson HS, Cox DG, et al. A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res 2007;67:2951-6.
8. Severi G, Hayes VM, Padilla EJ, et al. The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: results from an Australian population-based case-control study. Cancer Epidemiol Bio-markers Prev 2007;16:610-2.
9. Yeager M, Orr N, Hayes RB, et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007;39:645-9.
10. Haiman CA, Patterson N, Freedman ML, et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 2007;39:638-44.
11. Saramaki OR, Porkka KP, Vessella RL, Visakorpi T. Genetic aberrations in prostate cancer by microarray analysis. Int J Cancer 2006;119:1322-9.
12. Latil A,Vidaud D,Valeri A, et al. htert expression correlates with MYC over-expression in human prostate cancer. Int J Cancer 2000;89:172-6.
13. Sato H, Minei S, Hachiya T, YoshidaT,Takimoto Y. Fluorescence in situ hybridization analysis of c-myc amplification in stage TNM prostate cancer in Japanese patients. IntJ Urol 2006;13:761-6.
14. Ribeiro FR, Henrique R, Martins AT, Jeronimo C, Teixeira MR. Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients. Eur Urol 2007;52:116-25.
15. Gudmundsson J, Sulem P, Manolescu A, et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007;39:631-7.
16. Christensen GB, Camp NJ, Farnham JM, Cannon-Albright LA. Genome-wide linkage analysis for aggressive prostate cancer in Utah high-risk pedigrees. Prostate 2007;67:605-13.
17. Valeri A, Briollais L, Azzouzi R,et al. Segregation analysis of prostate cancer in France: evidence for autosomal dominant inheritance and residual brother-brother dependence. Ann Hum Genet 2003;67:125-37.
18. Pakkanen S, Baffoe-Bonnie AB, Matikainen MP, et al. Segregation analysis of1,546 prostate cancer families in Finland shows recessive inheritance. Hum Genet 2007;121:257-67.